The global STD diagnostics market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of STDs and the need for accurate diagnosis. The increasing awareness about STDs and their symptoms has led to an increase in testing for these diseases, which in turn has increased demand for STD diagnostics.
The global STD diagnostics market by type includes chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papilloma virus (HPV) testing and human immunodeficiency virus (HIV) testing. Chlamydia tests are expected to account for the largest share of this market during the forecast period due to its high prevalence among sexually active individuals aged 15-24 years old. Syphilis tests are expected to account for a significant share of this market due to its high incidence rate among adults aged 25-44 years old who have sex with other adults without using protection against STDs or HIV/AIDS infection. HPV tests are also expected be popular because HPV is one of the most common sexually transmitted infections worldwide that can lead up cervical cancer if left untreated; it can also cause genital warts in both men and women that may lead up penile cancer if left untreated; it can also cause anal cancer if left unprotected; it can also cause oropharyngeal cancers such as throat cancers if left unprotected; it can also cause vulvar cancer if left unprotected; it can also cause vaginal cancer if left unprotected; and finally, HPV may lead up vulvar intraepithelial neoplasia (VIN), which is an abnormal growth on your vulva that could become malignant over time unless treated early enough with surgery or laser therapy before becoming invasive carcinoma cells that invade nearby tissues). Human immunodeficiency virus (HIV) tests are another type included in this category because HIV is one of the most common sexually transmitted infections worldwide that leads up AIDS when not treated early enough with antiretroviral therapy drugs such as AZT or Zidovudine which suppress viral replication by inhibiting reverse transcriptase activity thereby preventing new viruses from being made).
Some Of The Growth Factors Of This Market:
- The increase in the number of people who are sexually active.
- The increase in the number of people who are not using condoms during sexual intercourse.
- The increase in the number of people who have multiple sexual partners.
- The lack of awareness about STDs and their symptoms.
- Lack of access to STD testing.
Industry Growth Insights published a new data on “STD Diagnostics Market”. The research report is titled “STD Diagnostics Market research by Types (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing), By Applications (Laboratory Testing, Point of Care Testing), By Players/Companies Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere”.
Scope Of The Report
Report Attributes
Report Details
Report Title
STD Diagnostics Market Research Report
By Type
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing
By Application
Laboratory Testing, Point of Care Testing
By Companies
Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global STD Diagnostics Market Report Segments:
The global STD Diagnostics market is segmented on the basis of:
Types
Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory Testing, Point of Care Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- ADI/American Diagnostica
- Agilent Technologies
- Alere/Biosite/Inverness
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data
- Decode Genetics
- Diadexus
- Diagnocure
- Diagnostica Stago/Trinity Biotech
- Diamedix
- Polymedco
- Qiagen
- Roche
- SDIX
- Sequenom
- Siemens
- Sienco
- Sysmex
- Takara Bio
- ThermoFisher
- Tosoh
- Wako
- Zycare/Alere
Highlights of The STD Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chlamydia Testing
- Syphilis Testing
- Gonorrhea Testing
- Herpes Simplex Virus Testing
- Human Papilloma Virus Testing
- Human Immunodeficiency Virus Testing
- Chancroid Testing
- By Application:
- Laboratory Testing
- Point of Care Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the STD Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
STD Diagnostics is a company that provides STD testing and treatment. It offers tests for HIV, syphilis, gonorrhea, chlamydia, and trichomoniasis.
Some of the key players operating in the std diagnostics market are Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere.
The std diagnostics market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. STD Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. STD Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. STD Diagnostics Market - Supply Chain
4.5. Global STD Diagnostics Market Forecast
4.5.1. STD Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. STD Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. STD Diagnostics Market Absolute $ Opportunity
5. Global STD Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. STD Diagnostics Market Size and Volume Forecast by Type
5.3.1. Chlamydia Testing
5.3.2. Syphilis Testing
5.3.3. Gonorrhea Testing
5.3.4. Herpes Simplex Virus Testing
5.3.5. Human Papilloma Virus Testing
5.3.6. Human Immunodeficiency Virus Testing
5.3.7. Chancroid Testing
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global STD Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. STD Diagnostics Market Size and Volume Forecast by Application
6.3.1. Laboratory Testing
6.3.2. Point of Care Testing
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global STD Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. STD Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global STD Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. STD Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global STD Diagnostics Demand Share Forecast, 2019-2026
9. North America STD Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America STD Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America STD Diagnostics Market Size and Volume Forecast by Application
9.4.1. Laboratory Testing
9.4.2. Point of Care Testing
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America STD Diagnostics Market Size and Volume Forecast by Type
9.7.1. Chlamydia Testing
9.7.2. Syphilis Testing
9.7.3. Gonorrhea Testing
9.7.4. Herpes Simplex Virus Testing
9.7.5. Human Papilloma Virus Testing
9.7.6. Human Immunodeficiency Virus Testing
9.7.7. Chancroid Testing
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America STD Diagnostics Demand Share Forecast, 2019-2026
10. Latin America STD Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America STD Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America STD Diagnostics Market Size and Volume Forecast by Application
10.4.1. Laboratory Testing
10.4.2. Point of Care Testing
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America STD Diagnostics Market Size and Volume Forecast by Type
10.7.1. Chlamydia Testing
10.7.2. Syphilis Testing
10.7.3. Gonorrhea Testing
10.7.4. Herpes Simplex Virus Testing
10.7.5. Human Papilloma Virus Testing
10.7.6. Human Immunodeficiency Virus Testing
10.7.7. Chancroid Testing
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America STD Diagnostics Demand Share Forecast, 2019-2026
11. Europe STD Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe STD Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe STD Diagnostics Market Size and Volume Forecast by Application
11.4.1. Laboratory Testing
11.4.2. Point of Care Testing
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe STD Diagnostics Market Size and Volume Forecast by Type
11.7.1. Chlamydia Testing
11.7.2. Syphilis Testing
11.7.3. Gonorrhea Testing
11.7.4. Herpes Simplex Virus Testing
11.7.5. Human Papilloma Virus Testing
11.7.6. Human Immunodeficiency Virus Testing
11.7.7. Chancroid Testing
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe STD Diagnostics Demand Share, 2019-2026
12. Asia Pacific STD Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific STD Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific STD Diagnostics Market Size and Volume Forecast by Application
12.4.1. Laboratory Testing
12.4.2. Point of Care Testing
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific STD Diagnostics Market Size and Volume Forecast by Type
12.7.1. Chlamydia Testing
12.7.2. Syphilis Testing
12.7.3. Gonorrhea Testing
12.7.4. Herpes Simplex Virus Testing
12.7.5. Human Papilloma Virus Testing
12.7.6. Human Immunodeficiency Virus Testing
12.7.7. Chancroid Testing
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific STD Diagnostics Demand Share, 2019-2026
13. Middle East & Africa STD Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa STD Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa STD Diagnostics Market Size and Volume Forecast by Application
13.4.1. Laboratory Testing
13.4.2. Point of Care Testing
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa STD Diagnostics Market Size and Volume Forecast by Type
13.7.1. Chlamydia Testing
13.7.2. Syphilis Testing
13.7.3. Gonorrhea Testing
13.7.4. Herpes Simplex Virus Testing
13.7.5. Human Papilloma Virus Testing
13.7.6. Human Immunodeficiency Virus Testing
13.7.7. Chancroid Testing
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa STD Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global STD Diagnostics Market: Market Share Analysis
14.2. STD Diagnostics Distributors and Customers
14.3. STD Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ADI/American Diagnostica
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Agilent Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Alere/Biosite/Inverness
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Axis-Shield
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beckman Coulter/Danaher
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Becton Dickinson
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bio/Data
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Decode Genetics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Diadexus
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Diagnocure
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Diagnostica Stago/Trinity Biotech
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Diamedix
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Polymedco
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Qiagen
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Roche
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. SDIX
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Sequenom
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Siemens
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Sienco
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
